BioNTech preps hiring spree at mRNA vaccine plant, boosting workforce by 50%
Summary : In just two short years, BioNTech will have more than doubled the size of its workforce at the German biologics…
Summary : In just two short years, BioNTech will have more than doubled the size of its workforce at the German biologics…
Summary : Beckley Psytech leads a new project focused on addressing psychiatric and neurological conditions through the use of psychedelic medicines. As interest…
Summary : The phase 3 trial involved over 800 candidates to assess ensifentrine when administered as a maintenance therapy to patients diagnosed…
Chennai: The city-based laboratory says it has developed an RT-PCR test kit that can detect the Covid-19 virus in 45 minutes and…
Synopsis : The National Institutes of Health (NIH) is awarding $170 million over five years, pending the availability of funds, to clinics…
Summary : Successfully enrolled first-line metastatic pancreatic and third-line metastatic colorectal safety run-ins Company moving to full enrollment pending independent safety review…
Summary : More than 1.2 million people – and potentially millions more – died in 2019 as a direct result of antibiotic-resistant…
Summary : Psyros Diagnostics has signed an agreement to be acquired by the Swedish company, Prolight Diagnostics AB. Psyros’s ground-breaking Point-of-Care (POC)…
Summary : After a high-profile study turned up safety risks for Pfizer’s JAK inhibitor Xeljanz last year, the FDA put the entire…
Synopsis : Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of…